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Background: The unprecedented number of youths engaged in nonmedical use of prescription opioids (POs), as well as the
myriad negative consequences of such misuse, emphasizes the importance of prevention efforts targeting this public health crisis.
Although there are several science-based, interactive drug abuse prevention programs focused on preventing the use of
nonprescription drugs in youths, to our knowledge, there are no science-based interactive programs that focus on the prevention
of PO abuse among adolescents.
Objective: The aim of this study was to develop and conduct a formative evaluation of a science-based interactive Web-based
program focused on the prevention of PO abuse among adolescents aged 12 to 17 years (Pop4Teens). This study was conducted
to prepare for a randomized controlled trial designed to evaluate the effectiveness of Pop4Teens compared with an active control
website, JustThinkTwice.com (Drug Enforcement Administration), in impacting knowledge and attitudes about POs and perceptions
of risk associated with the abuse of POs, as well as intentions to use and actual use of POs.
Methods: We conducted 6 focus groups with 30 youths (a mean of 5 per group: the eligibility being aged 12-19 years) along
a continuum of exposure to POs (in treatment for opioid use disorder, in general treatment for other substance use disorder,
prescribed an opioid, and opioid-naïve) and writing sessions with 30 youths in treatment for opioid use disorder (12-19 years) to
inform the development of the Web-based prevention tool. Feasibility and acceptability of a prototype of the Web-based intervention
were then assessed through individual feedback sessions with 57 youths (drawn from the same populations as the focus groups).
Results: We successfully completed the development of a Web-based PO abuse prevention program (Pop4Teens). Analyses of
focus group transcripts informed the development of the program (eg, quiz content/format, script writing, and story editing).
Selected writing session narratives anchored the planned scientific content by lending credibility and informing the development
of compelling storylines intended to motivate the youth to engage with the program. Feedback session data indicated that the
Web-based tool could be potentially useful and acceptable. In addition, feedback session participants demonstrated significant
increases in their knowledge of key topics related to the prevention of PO abuse after the exposure to sections of the Web-based
program.
Conclusions: The opioid crisis is predicted to get worse before it gets better. An effective response will likely require a
multipronged strategy inclusive of effective evidence-based prevention programs acceptable to, and accessible by, a majority of
youths.
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Introduction
Background
Nonmedical use of prescription opioids (NMUPO) among
adolescents—use of a prescription without or inconsistent with
a doctor’s order—is an escalating public health concern. Despite
a plateauing of this type of drug use among youths in the past
several years, 14.0% (2068/14,765) of a sample of high school
students in a nationally representative study in 2017 endorsed
lifetime misuse of prescription opioids (POs) [1]. Recent
investigations underscore the gravity of the negative and
potentially lifelong consequences associated with early-onset
PO misuse. Strong associations between younger age of opioid
initiation and heightened risk of opioid use disorders later in
life have been demonstrated across a gamut of retrospective and
longitudinal studies [2-4]. One study’s epidemiologic calculation
suggests that for roughly 8 million adolescents (12-21 years)
who engaged in NMUPO between 2002 and 2013,
approximately 42,000 to 58,000 met the criteria for opioid use
disorder— during each year —within 12 months after the onset
of their nonmedical use [5]. This conversion rate from
experimentation to opioid use disorder reveals the addictive
potential of this class of drugs. In addition, a prospective
nationally representative study of high school seniors
demonstrated that prescribed opioid use before high school
graduation is independently associated with a 33% increase in
the risk of future opioid misuse after high school. Notably, this
association is concentrated among youths who had little to no
history of drug use and disapproving attitudes toward illegal
drug use at baseline [6].
NMUPO is also a strong predictor of heroin use onset among
adolescents and young adults [4,7-9]. In a national study of
youth aged 12 to 21 years, those who reported past NMUPO
had a 13-fold increased risk of heroin initiation compared with
those with no previous history of such use [10]. Young people
who use POs nonmedically are also significantly more likely
to experience major depressive episodes (MDEs) [11], as well
as sexual violence [9,12], compared with their nonabusing peers.
Further underscoring the urgent need for prevention of NMUPO
among the youth, recent statistics show that drug overdose is
now the leading cause of death for adults aged under 45 years
in the United States, driven largely by opioid-related overdoses,
which accounted for most of the 63,632 lethal overdoses in
2016 (65.99% (41,997/63,632) [13,14]. Between 1999 and 2016,
the drug overdose death rate increased by 268.2% among those
aged 15 to 19 years (N=7,921 adolescent deaths 1999-2016)
[15]. Though the effects of introducing opioids to the developing
brains of adolescents may be harmful in ways that are not yet
well understood, the most immediate consequences are likely
to impact cognitive, social, and emotional development [16,17].
For example, some data show that treatment-seeking adolescents
with opioid use disorder demonstrate working memory
impairment [18], as well as daily drug using/seeking routines
that leave little room for healthy social development and
alternative interests [19]. In addition, in a recent study using a
nationally representative dataset, youths who engaged in
NMUPO were 120% more likely to experience an MDE in their
lifetime [20]. The current National Institutes of Health (NIH)
initiative, the Adolescent Brain Cognitive Development Study
[21], designed to prospectively study the risk and protective
factors influencing substance use and its consequences among
a cohort of 9- to 10-year-olds (for 10 years) will likely add much
to our understanding of developmental consequences. The
number of youths currently engaged in NMUPO, as well as the
possible consequences of such misuse, unequivocally
emphasizes the importance of prevention strategies targeting
this public health crisis.
Nationwide efforts to provide a comprehensive response to this
crisis include the following: the development and deployment
of interventions such as prescription drug monitoring programs
to reduce inappropriate prescribing of opioids and enable the
early identification of persons demonstrating problematic use
[22], increasing the number of prescribers who receive training
on pain management and safe opioid prescribing [23-25], and
expanding access to abuse-deterrent formulations to discourage
abuse [26]. There are also numerous efforts underway to
improve access to, and insurance coverage for, evidence-based
treatment for individuals with opioid use disorders [25,27]. The
availability of the opioid antagonist naloxone hydrochloride
(NARCAN), which reverses the potentially fatal respiratory
depression caused by heroin and other opioids, is increasing
among law enforcement and laypersons alike across the country
[28]. However, limited attention has been given to the
development of evidence-based prevention programs to deter
opioid misuse among the youth. The prevention program that
we have developed and plan to evaluate in an upcoming
randomized controlled trial is the first of its kind, to our
knowledge, as existing prevention programs do not incorporate
scientific knowledge about risk factors for PO abuse.
Risk factors for PO abuse differ from other drugs/illegal drugs
in significant ways: the vast majority of nonmedical PO users
report obtaining these medications for the first time from friends
or family [29], lowering the threshold to access in terms of both
response effort and costs; the perceived risks (eg, health and
legal) associated with the misuse of these medications are
significantly attenuated compared with other drugs of abuse
because of their prescription and approval for medical use
[30,31]; and opioid prescriptions for acute pain episodes set the
occasion for either the misuse of leftover medications [6,32,33]
or enticement of those youths who are prescribed opioids into
diverting (eg, selling, trading, and sharing) their medication for
monetary or social gain [34].
Irrespective of the specific risk factors associated with the use
of a particular class of drugs, effective drug abuse prevention
programs generally educate the youth about how specific drugs
work (mechanism of action) and typically focus on one of 2
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broad categories of skill training [35]: social influences and
training skills necessary to resist peer, family, media, and other
social influences known to promote drug use [36] and the
provision of more general skills training necessary for social
competency and the ability to cope with stressful life situations
[37]. Numerous qualitative and quantitative reviews of the
prevention science literature have demonstrated that substance
abuse prevention programs based on these approaches generally
increase protective factors, reduce risk factors, and produce
marked reductions in drug use among the youth [38]. In addition,
programs based on social influence and general skills training
models have been shown to be effective when delivered via
interactive, activity-oriented programs and not traditional,
didactic instructional techniques [39,40].
Digital platforms may provide a particularly appealing and
effective approach for prevention efforts designed to reach
adolescents. The traditional means of reaching the youth are
hindered by the costs associated with teacher/clinician-delivered
interventions as well as manifold issues that impede delivering
interventions with fidelity. However, interventions delivered
via digital platforms (eg, laptop, mobile phone, or computer)
boast of benefits that have greater appeal to the youth [41],
significantly reduced costs [42], standardized content delivery
[42], the potential for delivery across a multitude of settings
[43], and minimizing teaching and/or clinical staff burden
compared with traditional methods [44]. Underscoring the
opportunity afforded by digital platforms, as of 2018, 93.9%
(698/743) of teens reported going on the Web daily—including
44.9% (334/743) who said they go on the Web almost
constantly. These numbers are largely a function of mobile
device usage and/or ownership with nearly 95.0% (706/743) of
teens endorsing one or the other [45].
Published scientific literature on digital platforms for
interventions targeting adolescent substance abuse is burgeoning
[41,46].The number of publications describing technology-based
substance abuse prevention programs that aim for universal
application, that is, intended for all youths who endorse no past
alcohol or substance use, is significantly smaller. These
programs have demonstrated effectiveness in 3 contexts: primary
care [47], schools [48,49], and homes [50-53]. They target the
prevention of different classes of drug use, for example, alcohol
[49,50,54], cannabis [49,51], and tobacco [48] and generally
comprise interactive internet-based activities that function to
increase drug-related knowledge and shape user attitudes and
normative beliefs around substance use in ways that result in
abstinence or delayed onset of use [51]. All programs referenced
herein were found to be effective in reducing
intentions/expectations to use and/or endorse use.
Thus, although several science-based interactive drug abuse
prevention programs have been developed to prevent the use
of nonprescription drugs in youths, to our knowledge, there are
no published studies featuring science-based interactive
programs focused on the prevention of PO abuse among
adolescents. As described below, the scientific evidence
underpinning the Web-based adolescent prevention program
content that we described in this paper comes from the literature
on computer-delivered interventions [41,55,56],
computer-assisted instruction technology [57-59], and identified
risk factors for PO use among the youth [5,6,8,9,30,33,60].
The data presented in this paper are from a completed Phase I
of a Small Business Technology Transfer (STTR) grant from
the National Institute on Drug Abuse (NIDA; R41DA023731)
as well as a NIDA STTR Phase II grant (2R42DA023731–02).
These efforts extend our previous study, developing and
evaluating science-based digitally delivered substance abuse
prevention programs for the youth, with a focused goal to
prevent PO misuse among the youth.
Aims
The aim of the research reported herein was to develop and
conduct a formative evaluation of a science-based Web-based
interactive program focused on the prevention of PO abuse
among adolescents. This program is composed of 8 modules
addressing the following topics: What are POs?; misconceptions
that POs are safe and nonaddictive; misconceptions that using
POs without a prescription is not illegal; risks of PO misuse;
nonmedication alternatives for pain management; refusing offers
to misuse POs; refusing requests by others for a PO prescribed
to you; and how to know if you or someone you know may be
addicted. This study was conducted before conducting a
randomized controlled trial to evaluate the effectiveness of the
Web-based PO abuse prevention program, Pop4Teens, compared
with an active control, the JustThinkTwice.com website (Drug
Enforcement Administration), in impacting attitudes about,
knowledge and perceptions of risk associated with the abuse of
POs, as well as intentions to use and actual use of POs. The
results of the randomized controlled trial will be published
separately once the trial is completed.
Methods
Design
Our iterative development process spanned Phase I (when 3
modules were developed, ie, introduction, what are POs, and
misconceptions that POs are safe and nonaddictive) and Phase
II (when the remaining modules were developed—see above).
We did not include the introduction module in the final product
as it had become redundant because of the inclusion of the
content of subsequent modules. These activities included the
conduct of the following: 6 focus groups with youths along a
continuum of exposure to POs (in treatment for opioid use
disorder, in general treatment for other substance use disorder,
prescribed an opioid, and opioid naïve); writing sessions with
youths in treatment for opioid use disorder to inform the
development of the Web-based prevention tool as well as to
increase the overall credibility of the content; and one-on-one
feedback sessions with youths (drawn from the same populations
as the focus groups) . We conducted focus groups to help shape
program content development and feedback sessions to obtain
systematic feedback on the beta version of the Web-based
intervention.
Participants
Participants for focus groups and individual feedback sessions
were recruited from a treatment program focused on the
treatment of opioid-dependent youths, a community-based
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adolescent substance abuse treatment program, and the
community via advertisements/flyers for Phase I and either a
community hospital setting or a treatment facility for
opioid-dependent adolescents and young adults for Phase II.
Participants for the Phase II writing sessions were recruited
exclusively from the latter. Participants in focus groups and
writing and feedback sessions in both Phases I and II were
compensated $30 for their time (see Table 1 for details on
activities, eligibility criteria, and sample sizes).
Table 1. Overview of aims and participant activities by phase.
Sample size (n)Eligibility criteriaEnd user activityPrimary aimsSmall Business Technology
Transfera Phase – Aim
6Youth 14-18: not in substance abuse
treatment / opioid naive
FGc 1Develop pilot content of a
Web-based POb abuse pre-
vention program for High
school-aged Youth
I – 1. (2010-2011)
5Youth 14-18: in treatment for wider
substance abuse issue
FG 2
1Youth 14-18: in treatment for opioid de-
pendence
FG 3 (Interview)d
30Youth 14-18: along a continuum of expo-
sure to opioids (paralleling groups from
FG 1, 2 and Interview)
Individual feedback
sessions
8Youth 12-19e: in treatment for prescrip-
tion opioid dependence
FG 1Complete development of
ALL components of a Web-
based PO abuse prevention
program/Integrate all compo-
nents into a unified, Inter-
net-based multimedia pack-
age to be run cross-platform
II – 1. (2014-2016)
6Youth 12-17f: not in substance abuse
treatment/ opioid naïve
FG 2
4Youth 12-17: prescribed an opioid in the
past year
FG 3
30Youth in treatment for opioid depen-
dence
Writing sessions
27Youth 12-19: along a continuum of expo-
sure to opioids (paralleling groups from
FG 4, 5 and 6)
Individual feedback
sessions
400 (planned)Youth 12-17, English literate, whose




Conduct a randomized, con-
trolled trial to evaluate the
effectiveness of a Web-
based PO abuse prevention
program
II – 2. (2017-2018)
aA program that expands funding opportunities in the federal innovation research and development arena.
bPO: prescription opioid.
cFG: focus group.
dWe were able to recruit only 1 adolescent who met the eligibility criteria and consequently conducted an in-depth interview instead of a focus group.
eThe eligible age range was broadened for youth in treatment for PO dependence due to the fact that most youth do not enter treatment for opioid
dependence before 16 years of age.
fThe target age range for Phase I (14-18) was determined to be too old in light of scientific literature related to prescription opioid misuse among youth
published between the funding of Phases I (2010) and II (2014). In the interests of (1) locating our work within the larger corpus of effective prevention
efforts targeting adolescent substance abuse in general (Hale et al, 2014), (2) attending to epidemiological work (Meier et al, 2012) cautioning against
designing prevention initiatives that focus on the later high school years, and (3) seeking to help youth on the younger tail of initiation of prescription
opioid abuse avoid the potentially significant negative long-term consequences of early experimentation (McCabe, 2007), we adjusted the range to
youth between the ages of 12-17 for Phase II.
Procedure
All relevant institutional review board approvals were obtained
before the commencement of each phase of the research.
Adolescents' parent/guardian provided consent for their child
(if aged <18 years) and adolescents provided assent (if aged
<18 years) or consent (if aged ≥18 years) to participate (with
the exception of the writing session, for which we obtained a
waiver of assent/consent because of its anonymity).
Focus Groups
We conducted the first series of 3 audiotaped 90-min focus
groups with the youths to determine how to best present the
information in the program to the target age group. The youths
provided input on all aspects of the program content, including
the structure and style of the program. Participants were asked
to brainstorm and systematically fine-tune the various
components of this program during these focus groups, which
were conducted before the planned pilot program content was
developed.
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Focus groups were conducted in a semistructured group
interview format, in which the content of the discussion was
guided by a list of key topics relevant to the 3 modules
developed in this phase of the development of the tool (eg, What
are POs?; What do you think they do?; and Why do you think
doctors prescribe opioid medications?). The youths were asked
a series of questions regarding the extent to which the language,
video, characters, graphics, and presentation style and structure
to be used in presenting the desired material (described below)
were (1) understandable, (2) engaging, and (3) relevant to their
experience and the experience of those their age. All data
obtained from focus groups were qualitative in nature and were
used to shape program development in a manner that is
developmentally appropriate for and acceptable to the target
audience.
The second series of 3 focus group discussions (designed to
inform the development of the remaining 6 modules using a
similar process as described in the previous section) were
structured by questions probing the following: misconceptions
that using POs without a prescription is not illegal, risks of PO
misuse, and how to know if you or someone you know is
addicted (focus group 1: youths in treatment for opioid
dependence); assessments of credibility and compelling nature
of stories written by youths in treatment (focus group 2:
opioid-naïve youths); and what teens need to know if prescribed
an opioid (physical, emotional, and social effects), impact of
experience on the future use of POs, and how to respond if
approached to share POs (focus group 3: youths prescribed an
opioid).
Writing Sessions
To strengthen the credibility of the prevention program, we
recruited youths in treatment for their opioid dependence from
a therapeutic substance abuse treatment center to write stories
describing topics of potential interest to program users, as well
as topics paralleling planned scientific content: their lives just
before using POs the first time, their motivations to use POs
the first time, how quickly the time elapsed between using POs
the first time and then losing control of their use, their
experiences of realizing that they had a problem with POs, and
also, how to know if you or someone you know is addicted to
POs. The need to protect the writers’ anonymity constrained
the content of the narratives. Treatment center staff led the
writing sessions to ensure no stories revealed the identities of
the authors or those of others around them. Writing sessions
occurred in small groups at times that were convenient for them
throughout a day of their treatment experience. They were
instructed to choose a pseudonym to put at the top of their paper,
along with age and race, and to tell their story without risking
the identity of friends or family members. There were no time
limits on the writing sessions other than those naturally imposed
by treatment program schedules. The staff reviewed the
narratives for any identifying information before sharing the
anonymous files with the research team. Our team used some
of these stories to anchor the Web-based program, as well as to
generate scripts for actors to portray some of this content in
video clips conveying planned content (eg, risks of PO use and
refusing requests from others for a PO prescribed to you). Input
from the focus groups, as well as the stories that best fit with
the planned content (eg, risks associated with opioid misuse),
was incorporated into the development of the beta version of
the Web-based program.
Feedback Sessions
During the iterative development process in each phase, we also
conducted one-on-one feedback sessions with the youths to (1)
enable them to access the program modules on a study phone,
tablet, or laptop and (2) systematically provide feedback on the
beta version of the Web-based program. After completing a
brief demographic form, participants completed a 2- to 5-item
presession knowledge test to probe baseline familiarity with the
content of the section topic to be reviewed. An example of a
multiple choice question from a knowledge test is, “Prescription
opioids vary in strength and the effects are ‘dose related,’
meaning ______________________.”
Participants then completed the Web-based module at their own
pace, answered the knowledge test items again, and completed
a brief 17-item feedback survey inclusive of 12 visual analog
scale (VAS) items and 5 open-ended response items. Possible
values for VAS scores ranged from 0 to 100 mm and were
anchored in terms of the variable of interest probed in the item.
For example, for the first item—“How interesting was the
section of the program you just completed?”—0 was anchored
by the phrase not interesting, whereas 100 was anchored by
very interesting. Most participants reviewed 2 modules in a
single feedback session and completed separate pre- and
postsession knowledge tests and feedback surveys for each
module (see Multimedia Appendix 1 for the 17-item feedback
survey).
Analysis
We transcribed the focus group audiotapes and reviewed the
transcripts while listening to the audiotapes to ensure accuracy.
The focus group data were thematically analyzed to inform the
development of the program. For the feedback sessions, mean
VAS scores were calculated for each item. Paired t tests were
used to compare pre- and postsession knowledge test accuracy
data, collapsed across modules and participants. Feedback
session data were used to inform program refinement before




Participants across development activities were predominantly
non-Hispanic white males. Of those queried, only a small
handful had previously participated in any drug prevention
program geared toward POs. Of the youths in treatment for
opioid dependence use disorder, the average age of first opioid
use was 14.7 years (SD 1.2) for youths in focus groups and
15.75 years (SD 2.4) for youths in writing sessions and half had
transitioned to heroin use before seeking help with their opioid
use (see Table 2 for more detail).
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21.83 (2.0)16.37 (2.2)16.77 (2.2)16.53 (1.1)16Age (years), mean (SD)
Gender, n (%)
9 (30)11 (41)11 (61)13 (43)5 (42)Female 
21 (70)16 (59)7 (39)17 (57)7 (58)Male 
Ethnicity, n (%)
13 (87)b26 (96)16 (89)27 (90)—aNon-Hispanic 
Race, n (%)
—24 (88)15 (83)15 (50)—White 
—1 (4) —6 (20)—Black 
—2 (8)3 (17)9 (30)—Mixed/other 
—1 (4)—1(3)1 (7)Previous experience w/ POc Drug Pre-
vention Program, n (%)
15.75 (2.4)—14.7 (1.2)d——Age at first PO use, mean (SD)




dApplies only to youth in focus group #1 (n=8).
Focus Groups
The first series of 3 focus groups were focused on gleaning an
understanding of what the youths know about POs, as well as
misconceptions that POs are safe and nonaddictive. The youths
were generally very well informed about the indication for POs.
However, they were equally uninformed in their assessment of
their addictive potential and associated risks of overdose.
Analysis of data from the second set of focus groups among the
youths in treatment for opioid dependence highlighted the
following themes: the latency between first use of opioids and
loss of control is so brief that most youths report not even
noticing (range: 3-8 months); self-medication of unwanted
feelings, combined with low threshold access to prescribed
medication, is the primary reason for many youths to first use
POs; and POs are perceived as the second most dangerous drug
(next to heroin) among the youth who have experimented with
many substances. The transcript data from the second focus
group of opioid naïve youths suggest that based on their reading
of the stories written by the youths in treatment, they believe
the program should avoid moralizing; laundry-list-style detailing
of negative consequences; and normalizing other drug use when
highlighting the severity of prescription and other opioid (eg,
heroin) abuse. The analysis also suggests that the youths believe
the program should include stories of how average kids have
gotten into trouble with POs to highlight the nondiscriminatory
dimension of opioid abuse among the youth (eg, a star athlete
and a kid from a happy family).
Finally, the youths prescribed an opioid in the past year who
participated in a focus group reviewed the refusal skill scripts
drafted by research team members and provided written edits.
The youths provided valuable insights on how to increase the
credibility of the refusal skill script for those who may want to
know how to refuse requests by others for an opioid prescribed
to you. Specifically, the youths feel that if anyone approaches
you to share or sell your prescription pain medication, the
overwhelming message needs to be one of consternation and
affront that someone would consider asking for something that
you need to manage your injury.
Writing Sessions
The writing session stories varied in length from 2 paragraphs
to 5 pages of written text, single-spaced. Members of our
research team identified narratives for program inclusion by
comparing rankings based on the quality of the writing, as well
as the extent to which narrative content matched planned content
(eg, if a youth wrote about the challenges of saying no when
offered a Percocet, this content parallels the planned module
on how to refuse offers to misuse an opioid). Once the narratives
were selected, we worked with a multidisciplinary media
company to audition and identify actors to read the selected
youth narratives to be recorded for program inclusion.
Feedback Sessions
Each of the participants recruited for individual feedback
sessions reviewed 2 modules/program sections on one of the
following platforms: mobile phone, tablet, or laptop. Feedback
sessions were conducted individually, such that the participants
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individually interacted with the computer program. Scores
indicate that participants made significant knowledge gains.
For the modules developed in Phase I, the mean number of
correctly answered items on the knowledge pre- and posttests
was 3.65 (SD 1.46) and 4.4 (SD 0.75; t19=3.866; P<.001) for
youths in treatment for opioid dependence, 2.5 (SD 1.27) and
4.4 (SD 0.68; t19=7.292; P<.001) for youths in general substance
abuse treatment, and 3.1 (SD 0.72) and 4.4 (SD 0.75; t19=5.94;
P<.001) for opioid naïve youths, respectively. For the 6 modules
developed in Phase II, the mean number of correctly answered
items on the knowledge pre- and posttests was 3.54 (SD 0.88)
and 4.0 (SD 0.78; t23=−2.696; P<.05) for youths in treatment
and 3.3 (SD 1.21) and 4.13 (SD 0.86; t29=−5.473; P<.001), for
opioid naïve youths, respectively. See Figure 1 for a review of
these data in terms of percent correct in the pre- and
postknowledge test. Participants also rated the program sections
positively. As shown in Figure 2, several of the responses to
the 12 VAS items on the feedback session survey instrument
fell between 80 and 100, indicating that participants found the
modules to be easy to use, understandable, and useful as part
of a drug prevention program and they also liked using
technology and liked the videos. The remaining scale scores
(eg, interesting, useful, new information, answer questions,
applicable to others you know, comparable to other information
or treatment on this topic, and helpful [in terms of] change[ing]
behavior) fell between 60 and 80, with the exception of 1 item
that probed the applicability of the content to one’s own life.
This item had a mean score of 49 among opioid naïve youths
(SD 27.03), which is not surprising given that the program is
anchored by stories of youths in treatment for opioid
dependence. In addition to the VAS items, participants were
asked the following open-ended questions: “What did you like
most about the program?”; “What did you like least?”; and
“What suggestions might you make to improve the program?”.
Participants in both groups overwhelmingly liked the stories
(eg, “I mainly liked the person story about a young adult that
actually experienced an addiction problem. It makes the program
more real because it is based on a real person”) and videos (eg,
“I liked the three videos I viewed because at times when they
were a bit corny and funny, they got the point across in a
relatable and effective way”) the best. The youths in treatment
ranked the stories as most preferred, and opioid naïve youths
ranked the videos as most preferred but each group
predominantly referenced these 2 features as the best. What the
youths liked least was unanimous: the quizzes were least liked
across all groups of youths (eg, “I liked the quiz the least
because it kept asking the same questions”). Suggestions for
improvement were largely feedback on how to improve the
quizzes (eg, “Don’t’ time the questions” and “Make quizzes
less repetitive”).
Figure 1. Pre- and postknowledge test scores: Phases 1 and 2 (P1, P2).
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Figure 2. Feedback survey results.
Development Product: Pop4Teens Program
On the basis of the information gleaned from the development
activities, our technology team completed the final version of
the Web-based intervention to be run cross-platform (ie, on
mobile devices, tablets, and laptops). The 4 cornerstones of the
Pop4Teens program are as follows: 8 stories of real youths in
treatment for opioid use disorders and their companion lessons,
videos, and quizzes. The stories provide an entrée to the program
and potentially strengthen the credibility and compelling nature
of the content by offering real-world experiential information
on motivations to use POs for the first time, how quickly the
time elapses between using POs the first time and losing control
of use, experiences of realizing that the youths had a problem
with POs, and how to know if you or someone you know are
addicted to POs (see Multimedia Appendix 2). Lessons are
bullet-point scientific summaries that accompany individual
stories to reinforce content (see Multimedia Appendix 3). A
total of 6 short (approximately 5-min) videos were the products
of scripts that we created based on planned skill-building content
as well as feedback from focus group youths. Working with a
multimedia production company, we auditioned and identified
actors to act out 3 separate skill-based scenarios: how to refuse
offers to misuse opioids, how to refuse requests by others for a
PO prescribed to you, and how to nonmedically manage pain
through controlled breathing and relaxation exercise. In addition,
the program includes 2 informational videos (What are
prescription opioids? and Misconceptions that prescription
opioids are safe and nonaddictive) developed during Phase 1
of the STTR grant mechanism (see Multimedia Appendix 4).
Finally, the lessons provide the source material for the quiz
questions (see Multimedia Appendix 5).
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Though time consuming, there is no substitute for enlisting
potential end users in the development activities for
Web-delivered intervention programs, for example,
user-centered design [61] and behavioral science–informed user
experience design [62,63]. A key element in the development
of new technologies for behavior change is whether it suits its
purpose and meets users’ needs and expectations [64]. Through
the engagement of youths along a continuum of exposure to
opioids through focus groups and writing and feedback sessions,
Pop4Teens reflects the perspectives of these youths with the
goals of maximizing acceptability, engagement, usability, utility,
relevance, credibility, and, ultimately, effectiveness in reaching
program outcomes.
Focus group input helped shape the Pop4Teens program in
significant ways, several of which warrant underscoring. First,
the research team had chosen select stories produced by the
youths (ie, youths in treatment on their loss of control) for
inclusion in the program. However, after enlisting the input of
opioid naïve youths on these top-ranked stories, several were
swapped for alternatives that were less laundry-listy of negative
consequences or edited to remove what opioid-using youths
found to be the normalization or minimization of other drug
use. Second, the importance of the input from youths who had
been legitimately prescribed an opioid that directed the
emotional tone of how to respond if/when a friend requests to
use medication prescribed to them for an injury cannot be
overstated. The participants in this focus group were unanimous
in their feeling that the response needs to be one of indignation
and affront because in their collective experience, most
friends/acquaintances do not accept no for an answer and often
persist in their pressure to divert medications. This information
was critical in the development of the skill-based video on the
same topic. Third, the pervasive input from youths in treatment
for opioid use disorder on the latency between first use and loss
of control of PO misuse functioned to make this a point that we
highlight repeatedly in the program. The youths in this focus
group wanted to make sure we conveyed strongly that these
drugs are not similar to other drugs of experimentation because
of their addictive potential and loss of control.
The decision to enlist youths in treatment to share their stories
was based on the voluminous literature on the social learning
theory [65] which suggests that behavior change resulting from
interactions with peers may be more likely than interactions
with others (eg, in this case, adults, experts, and scientists)
because peers are perceived to be more credible role models
and enhance self-efficacy. Including youths in treatment to write
about their experiences of losing control of PO misuse as part
of the development process ultimately served a dual purpose.
On the one hand, feedback session data support the stories’
inclusion to increase engagement with the program. On the
other hand, the youths who provided their stories widely
reported being grateful for the opportunity to turn a very dark
period in their lives into something potentially positive and
lifesaving for other youths. Finally, feedback session data
demonstrate the promise and potential effectiveness of a
Web-based approach to preventing opioid misuse among teens,
given the statistically significant increases in participant
knowledge between pre- and postsession module reviews as
well as the overall positive assessment of the program.
The widespread use of technology among the youth highlights
the important opportunities for delivering effective
technology-based universal prevention interventions such as
Pop4Teens to this group. Applicability of this technology-based
tool may include its use across a range of settings, including
primary care [48], schools [50,66,67], and individual homes
[52,54,68-70]. In the primary care setting, Pop4Teens could
conceivably be suggested to the youth as part of universally
targeted care approaches within primary care practices across
the country. For example, once a young person turns 12 years
of age, the program could be part of a package of behavioral
health recommendations that are considered part of the annual
visit and thus recommended until the youth turns 17 years of
age. In school settings, where most prevention interventions are
delivered, Pop4Teens could be adopted as a stand-alone unit
on POs (especially in communities hardest hit by the epidemic)
or could be used in conjunction with other intervention content
to expand the current drug prevention programming. Finally,
the Pop4Teens tool might conceivably become a tool that parents
and youths could access for free without barriers, off the
internet.
Conclusions
The opioid crisis is predicted to get worse before it gets better
[71]. An effective response will likely require a multipronged
strategy inclusive of improved regulation and monitoring of
opioid prescribing, increased support for effective nonopioid
approaches to pain management, and increased availability of
affordable, evidence-based treatment options for the millions
of Americans battling opioid use disorders. Effective,
evidence-based prevention programs to help young people steer
clear of the enormous sink hole into which tens of thousands
have stumbled, including those who will not emerge, and the
others who struggle mightily to claw their way out are also
needed. Pop4Teens is the first science-based interactive
Web-based program focused on the prevention of PO abuse
among adolescents. Results from an ongoing randomized
controlled trial evaluating Pop4Teens will help determine
whether a tool of this type is effective in the prevention of PO
misuse among adolescents. We plan to publish outcome data
upon completion of the trial in 2019.
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